Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 6.50 +0.61 (10.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.89 | 52 Week High | $9.58 | |||
| Open | $6.05 | 52 Week Low | $2.34 | |||
| Day High | $6.59 | P/E | N/A | |||
| Day Low | $5.65 | EPS | $-0.34 | |||
| Volume | 27,668 | |||||
